Rowland Charles A Jr - Net Worth and Insider Trading

Rowland Charles A Jr Net Worth

The estimated net worth of Rowland Charles A Jr is at least $4 Million dollars as of 2024-04-28. Rowland Charles A Jr is the Director of Viking Therapeutics Inc and owns about 30,000 shares of Viking Therapeutics Inc (VKTX) stock worth over $2 Million. Rowland Charles A Jr is the Director of Generation Bio Co and owns about 534,757 shares of Generation Bio Co (GBIO) stock worth over $2 Million. Rowland Charles A Jr is also the Director of Blueprint Medicines Corp and owns about 3,562 shares of Blueprint Medicines Corp (BPMC) stock worth over $331,266. Besides these, Rowland Charles A Jr also holds Nabriva Therapeutics PLC (NBRVF) . Details can be seen in Rowland Charles A Jr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Rowland Charles A Jr has not made any transactions after 2023-12-04 and currently still holds the listed stock(s).

Transaction Summary of Rowland Charles A Jr

To

Rowland Charles A Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rowland Charles A Jr owns 7 companies in total, including Nabriva Therapeutics PLC (NBRVF) , Blueprint Medicines Corp (BPMC) , and Orchard Therapeutics PLC (ORTX) among others .

Click here to see the complete history of Rowland Charles A Jr’s form 4 insider trades.

Insider Ownership Summary of Rowland Charles A Jr

Ticker Comapny Transaction Date Type of Owner
NBRVF Nabriva Therapeutics PLC 2022-08-01 director
BPMC Blueprint Medicines Corp 2020-12-17 director
ORTX Orchard Therapeutics PLC 2020-01-01 director
GBIO Generation Bio Co 2023-12-04 director
VKTX Viking Therapeutics Inc 2023-05-16 director
VTAE Vitae Pharmaceuticals Inc 2016-10-25 director
BINDQ DNIB Unwind Inc 2016-08-26 director

Rowland Charles A Jr Latest Holdings Summary

Rowland Charles A Jr currently owns a total of 4 stocks. Among these stocks, Rowland Charles A Jr owns 30,000 shares of Viking Therapeutics Inc (VKTX) as of May 16, 2023, with a value of $2 Million and a weighting of 54.22%. Rowland Charles A Jr owns 534,757 shares of Generation Bio Co (GBIO) as of December 4, 2023, with a value of $2 Million and a weighting of 37.72%. Rowland Charles A Jr also owns 3,562 shares of Blueprint Medicines Corp (BPMC) as of December 17, 2020, with a value of $331,266 and a weighting of 8.06%. The other 1 stocks Nabriva Therapeutics PLC (NBRVF) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Rowland Charles A Jr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VKTX Viking Therapeutics Inc 2023-05-16 30,000 74.31 2,229,300
GBIO Generation Bio Co 2023-12-04 534,757 2.90 1,550,795
BPMC Blueprint Medicines Corp 2020-12-17 3,562 93.00 331,266
NBRVF Nabriva Therapeutics PLC 2022-08-01 611 0.00 0

Holding Weightings of Rowland Charles A Jr


Rowland Charles A Jr Form 4 Trading Tracker

According to the SEC Form 4 filings, Rowland Charles A Jr has made a total of 1 transactions in Viking Therapeutics Inc (VKTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Viking Therapeutics Inc is the sale of 40,000 shares on May 16, 2023, which brought Rowland Charles A Jr around $1,000,000.

According to the SEC Form 4 filings, Rowland Charles A Jr has made a total of 6 transactions in Generation Bio Co (GBIO) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Generation Bio Co is the acquisition of 342,960 shares on December 4, 2023, which cost Rowland Charles A Jr around $476,714.

According to the SEC Form 4 filings, Rowland Charles A Jr has made a total of 3 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Blueprint Medicines Corp is the sale of 10,909 shares on December 17, 2020, which brought Rowland Charles A Jr around $1 Million.

More details on Rowland Charles A Jr's insider transactions can be found in the Insider Trading History of Rowland Charles A Jr table.

Insider Trading History of Rowland Charles A Jr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rowland Charles A Jr Trading Performance

GuruFocus tracks the stock performance after each of Rowland Charles A Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rowland Charles A Jr is 45.53%. GuruFocus also compares Rowland Charles A Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rowland Charles A Jr within 3 months outperforms 4 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Rowland Charles A Jr's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Rowland Charles A Jr

Average Return

-6.52%

Average return per transaction

Outperforming Transactions

43%

3 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 24.58 45.53 21.69 -6.52 -35.46 -39.28
Relative Return to S&P 500(%) 24.57 38.62 12.76 -26.91 -46.05 -54.87

Rowland Charles A Jr Ownership Network

Ownership Network List of Rowland Charles A Jr

No Data

Ownership Network Relation of Rowland Charles A Jr


Rowland Charles A Jr Owned Company Details

What does Nabriva Therapeutics PLC do?

Who are the key executives at Nabriva Therapeutics PLC?

Rowland Charles A Jr is the director of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .

Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nabriva Therapeutics PLC Insider Transactions

No Available Data

Rowland Charles A Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Rowland Charles A Jr. You might contact Rowland Charles A Jr via mailing address: 3338 Lancashire Rd, Furlong Pa 18925.

Discussions on Rowland Charles A Jr

No discussions yet.